@article{11092,
  keywords = {Pregnancy, Female, Humans, Teratogens/toxicity, *Abnormalities, Drug-Induced/epidemiology/etiology, *Teratogenesis, United Kingdom, *Pregnancy Complications},
  author = {C. Lee and S. Rizzi and A. Bierrenbach and L. Antunes and N. Nissinen and O. Rocha and J. Campbell and C. Minassian and S. Hodgson and A. Broe},
  title = {Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register},
  year = {2024},
  journal = {Pharmacoepidemiol Drug Saf},
  volume = {33},
  edition = {2024/02/16},
  number = {2},
  pages = {e5761},
  isbn = {1053-8569},
  doi = {10.1002/pds.5761},
  note = {1099-1557
Lee, Christopher
Rizzi, Silvia
Bierrenbach, Ana Luiza
Antunes, Luis
Nissinen, Niina-Maria
Rocha, Olga
Campbell, Jennifer
Orcid: 0000-0002-0684-4437
Minassian, Caroline
Orcid: 0000-0001-9406-1928
Hodgson, Susan
Broe, Anne
Orcid: 0000-0002-4149-8808
Letter
England
Pharmacoepidemiol Drug Saf. 2024 Feb;33(2):e5761. doi: 10.1002/pds.5761.},
  language = {eng},
}